Cargando…
Expression of a Splice Variant of CYP26B1 in Betel Quid-Related Oral Cancer
Betel quid (BQ) is a psychostimulant, an addictive substance, and a group 1 carcinogen that exhibits the potential to induce adverse health effects. Approximately, 600 million users chew a variety of BQ. Areca nut (AN) is a necessary ingredient in BQ products. Arecoline is the primary alkaloid in th...
Autores principales: | Chen, Ping-Ho, Lee, Ka-Wo, Hsu, Cheng-Chieh, Chen, Jeff Yi-Fu, Wang, Yan-Hsiung, Chen, Ker-Kong, Wang, Hui-Min David, Huang, Hurng-Wern, Huang, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4119653/ https://www.ncbi.nlm.nih.gov/pubmed/25114974 http://dx.doi.org/10.1155/2014/810561 |
Ejemplares similares
-
CYP26A1 Is a Novel Biomarker for Betel Quid-Related Oral and Pharyngeal Cancers
por: Chen, Ping-Ho, et al.
Publicado: (2020) -
The Influence of Monoamine Oxidase Variants on the Risk of Betel Quid-Associated Oral and Pharyngeal Cancer
por: Chen, Ping-Ho, et al.
Publicado: (2014) -
Adverse Health Effects of Betel Quid and the Risk of Oral and Pharyngeal Cancers
por: Chen, Ping-Ho, et al.
Publicado: (2017) -
Association Study between Novel CYP26 Polymorphisms and the Risk of Betel Quid-Related Malignant Oral Disorders
por: Wu, Shyh-Jong, et al.
Publicado: (2015) -
Genomic Alterations in Breast Cancer Patients in Betel Quid and Non Betel Quid Chewers
por: Kaushal, Mishi, et al.
Publicado: (2012)